Austria vs Iceland: Reported rate of new cervical cancer cases
Austria
6.23 per 100,000 women
in 2017
Iceland
6.24 per 100,000 women
in 2022
Austria rank
31st
Iceland rank
30th
Reported rate of new cervical cancer cases over time
- Austria
- Iceland
How they compare
Iceland currently reports 6.24 per 100,000 women against 6.23 per 100,000 women in Austria, a difference of 0.01 per 100,000 women.
The two have swapped places 5 times across 20 shared years of data; in 1998 it was Austria ahead.
Austria ranks 31st and Iceland ranks 30th of 46 countries.
Across the 3 decades both report, Austria averaged higher in 1 and Iceland in 2.
Head to head by decade
| Decade | Austria | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 8.66 per 100,000 women | 8.57 per 100,000 women | 0.0959 per 100,000 women | Austria |
| 2000s | 7.47 per 100,000 women | 8.54 per 100,000 women | 1.06 per 100,000 women | Iceland |
| 2010s | 6.11 per 100,000 women | 8.92 per 100,000 women | 2.81 per 100,000 women | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Austria or Iceland?
- Iceland, at 6.24 per 100,000 women against 6.23 per 100,000 women in Austria as of 2022.
- What is the difference in reported rate of new cervical cancer cases between Austria and Iceland?
- 0.01 per 100,000 women, with Iceland ahead.
- How many years of comparable data are there for Austria and Iceland?
- 20 years are reported by both, from 1998 to 2017.
- How do Austria and Iceland rank globally for reported rate of new cervical cancer cases?
- Austria ranks 31st and Iceland ranks 30th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.